Insilico Medicine
英矽智能
Insilico Medicine
Biotech/Healthcare
Insilico Medicine announced the completion of a $60 million Series D financing round. New investors included a large diversified asset management firm based on the U.S.
Latest round: IPO (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.